Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity Helen Sullivan,

Slides:

Advertisements

Similar presentations

Pregnancy rates after embryo transfer depend on the provider at embryo transfer22 Rhonda M Hearns-Stokes, M.D., Bradley T Miller, M.D., Lynette Scott,

Advertisements

Marko Niemimaa, M. D. , Seppo Heinonen, M. D. , Maija Seppälä, Ph. D

A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment Diane.

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Philip M. Sarrel, M. D. , Shannon D. Sullivan, M. D. , Ph. D

Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial Tasuku Harada,

Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis George Griesinger, M.D.,

Shannon D. Sullivan, M. D. , Philip M. Sarrel, M. D. , Lawrence M

Why consider vaginal drug administration?

Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated.

Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D

The human ovarian follicular fluid level of interleukin-8 is associated with follicular size and patient age Beth A. Malizia, M.D., Yoo Sang Wook, M.D.,

Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day.

A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment Diane.

Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study Arianna D'Angelo, M.D., Rachel.

Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating.

Vincenzo De Leo, M. D. , Valeria Scolaro, M. D

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles Angela R. Baerwald, Ph.D.,

Pharmacokinetic overview of Ortho Evra™/Evra™

Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D

Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women Carlos Iglesias, M.D., Manish Banker, M.D.,

Hongxia Li, M. D. , Jiangang Chen, M. D. , James W Overstreet, M. D

Is chemiluminescent immunoassay an appropriate substitution for radioimmunoassay in monitoring estradiol levels? Avner Hershlag, M.D., Michael Zinger,

Day 4 Estradiol Levels Predict Pregnancy Success in Women Undergoing Controlled Ovarian Hyperstimulation for IVF John Y Phelps, M.D., Adam S Levine,

Three-dimensional ultrasonographic ovarian measurements and in vitro fertilization outcome are related to age Sanja Kupesic, M.D., Ph.D., Asim Kurjak,

Follicle-stimulating hormone administered at the time of human chorionic gonadotropin trigger improves oocyte developmental competence in in vitro fertilization.

Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D

Zeev Shoham, M.D. Fertility and Sterility

Randomized comparison of different ovarian stimulation regimens for assisted reproductive technology in baboons (Papio anubis) Atunga Nyachieo, M.Sc.,

Angela R. Baerwald, Ph. D. , Olufemi A. Olatunbosun, M. D. , Roger A

A prospective evaluation of antral follicle function in women with 46,XX spontaneous primary ovarian insufficiency Ziad R. Hubayter, M.D., M.P.H., Vaishali.

Conversion of high-response gonadotropin intrauterine insemination cycles to in vitro fertilization results in excellent ongoing pregnancy rates Amy.

Angela R Baerwald, B. Sc. Hon. , Gregg P Adams, D. V. M. , M. S. , Ph

Katherine D. LaGuardia, M. D. , M. P. H. , Alan C. Fisher, Dr. P. H

Clinical Assessment of Recombinant Human Follicle-Stimulating Hormone in Stimulating Ovarian Follicular Development Before In Vitro Fertilization fn1

Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence Jeffrey T. Jensen, M.D.,

Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation Nam D. Tran, M.D., Ph.D., Lusine Aghajanova, M.D.,

Robotic-assisted laparoscopic ovarian tissue transplantation

Introduction Fertility and Sterility

Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer Shokichi Teramoto,

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis Rina Agrawal,

Volume 64, Issue 1, Pages (July 2003)

Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment

Luteal estradiol administration strengthens the relationship between day 3 follicle- stimulating hormone and inhibin B levels and ovarian follicular status

Efficiency of changing the embryo transfer time from day 3 to day 2 among women with poor ovarian response: A prospective randomized trial Mustafa Bahceci,

Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.

Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in.

Pyridostigmine cotreatment for controlled ovarian hyperstimulation in low responders undergoing in vitro fertilization–embryo transfer Chung-Hoon Kim,

Regulation of assisted reproductive technologies in the United States

Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women Hong Zang, M.D., Kjell Carlström,

Effects of oral and transdermal low-dose estrogen therapy on echocardiographic parameters of cardiac function Tatjana E Vogelvang, M.D., Marius J van.

Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception

Absence of corpus luteum rescue by chorionic gonadotropin in women immunized with a contraceptive vaccine Rahul Pal, Ph.D., Om Singh, Ph.D. Fertility.

Annette Gruschke, M.D., Herbert Kuhl, Ph.D. Fertility and Sterility

Anuja Dokras, M. D. , Ph. D. , Antonia Habana, M. D. , Juan Giraldo, M

Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone.

Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.

Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization Efstratios M Kolibianakis, M.D., Kostas.

Percutaneous oocyte retrieval from an inguinal ovary

First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for.

Serum levels of soluble vascular cell adhesion molecule-1 are decreased in women receiving oral contraceptives compared with normally menstruating women:

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles David.

Fertility after discontinuation of treatment with an oral contraceptive containing 30 μg of ethinyl estradiol and 2 mg of dienogest Inka Wiegratz, Ph.D.,

Microdose gonadotropin-releasing hormone agonist in the absence of exogenous gonadotropins is not sufficient to induce multiple follicle development

Ovarian follicular volume and follicular surface area are better indicators of follicular growth and maturation, respectively, than is follicular diameter

Use of recombinant human chorionic gonadotropin in ovulation induction

In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation

Kutluk Oktay, M. D. , Erkan Buyuk, M. D. , Zev Rosenwaks, M. D

Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cycles2

Superoxide dismutase activity in human follicular fluid after controlled ovarian hyperstimulation in women undergoing in vitro fertilization Luca Sabatini,

Presentation transcript:

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity Helen Sullivan, M.D., Hilary Furniss, Jurgen Spona, Ph.D., Max Elstein, M.D. Fertility and Sterility Volume 72, Issue 1, Pages 115-120 (July 1999) DOI: 10.1016/S0015-0282(99)00205-8

FIGURE 1 Mean diameter of largest follicle-like structure with 21- and 24-day regimens. ■, 7-day pill-free interval; ■, 4-day placebo-pill interval; --○--, 24-day; –■–, 21-day. Fertility and Sterility 1999 72, 115-120DOI: (10.1016/S0015-0282(99)00205-8)

FIGURE 2 Mean serum 17-β-E2 concentration with 21- and 24-day regimens. ■, 7-day pill-free interval; ■, 4-day placebo-pill interval; --○--, 24-day; –■–, 21-day. Fertility and Sterility 1999 72, 115-120DOI: (10.1016/S0015-0282(99)00205-8)